Ranitidine tablets bulk supplier for pharma manufacturers

Ranitidine Tablets 75 mg, 150 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 75 mg, 150 mg, 300 mg

Reference Brands: Zantac(US & EU)- dis.contd in many markets

Ranitidine tablets are H2 receptor antagonists that block histamine receptors in the stomach lining, reducing acid secretion. They provide relief from heartburn, GERD, ulcers, and acid indigestion, promote healing of ulcers, and prevent acid-related damage, improving comfort and preventing complications associated with excessive gastric acid.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ranitidine tablets were widely used for acid-related disorders in the US and EU, supported by comprehensive regulatory dossiers demonstrating safety, efficacy, and manufacturing quality. However, due to concerns over NDMA impurities, many countries, including the US and EU, have withdrawn ranitidine products from the market. Regulatory authorities have implemented strict testing and monitoring protocols for existing stocks. For detailed information on regulatory status, dossiers, and licensing requirements for alternatives, visit Pharmatradz. Stay informed on the latest updates regarding the regulatory landscape for ranitidine and safe alternatives in global markets.

Ranitidine Tablets — third party manufacturing & bulk supply

Ranitidine Tablets 75 mg, 150 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ranitidine Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ranitidine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ranitidine Tablets →

Back to Listing

Frequently Asked Questions

Ranitidine is used to reduce stomach acid production and treat conditions such as gastric ulcers, duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.

Ranitidine is made from Ranitidine Hydrochloride, a compound that blocks histamine H2 receptors in the stomach, thereby reducing acid secretion.

The most common trade name was Zantac, along with Rantac, Aciloc, Histac, and Zinetac in various regions.

Ranitidine was originally developed and marketed under the brand Zantac by GlaxoSmithKline (GSK), with many global and Indian manufacturers producing generic versions.

The generic name is Ranitidine Hydrochloride.

Brand names included Zantac, Rantac, Aciloc, Histac, and Zinetac.

Ranitidine was manufactured globally, including in the USA, Europe, India, and other pharmaceutical manufacturing hubs, though current production depends on regulatory approvals due to safety concerns.